Statements of Changes in Equity - USD ($) |
Ordinary shares [member]
Alps Global Holding Berhad [Member]
|
Ordinary shares [member] |
Ordinary shares [member]
Alps Life Science Inc [Member]
|
Shares Application Money [member]
Alps Global Holding Berhad [Member]
|
Reserve of Change In Value Of Merger Reserves [member]
Alps Global Holding Berhad [Member]
|
Reserve of change in value of foreign currency basis spreads [member]
Alps Global Holding Berhad [Member]
|
Retained earnings [member]
Alps Global Holding Berhad [Member]
|
Retained earnings [member] |
Retained earnings [member]
Alps Life Science Inc [Member]
|
Equity attributable to owners of parent [member]
Alps Global Holding Berhad [Member]
|
Non-controlling interests [member]
Alps Global Holding Berhad [Member]
|
Total Equity [Member]
Alps Global Holding Berhad [Member]
|
Alps Global Holding Berhad [Member] |
Total |
Alps Life Science Inc [Member] |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Mar. 31, 2022 | $ 10,865,233 | $ 333,679 | $ (3,067,047) | $ (5,622,603) | $ 2,509,262 | $ (24,231) | $ 2,485,031 | |||||||||||
| IfrsStatementLineItems [Line Items] | ||||||||||||||||||
| Issuance of shares | 224,605 | (224,605) | ||||||||||||||||
| Loss for the financial period, representing total comprehensive loss for the financial period | (729,159) | (729,159) | (703) | (729,862) | $ (729,862) | |||||||||||||
| Other comprehensive loss | (124,413) | (124,413) | (124,413) | (124,413) | ||||||||||||||
| Total comprehensive loss for the financial year | (124,413) | (729,159) | (853,572) | (703) | (854,275) | (854,275) | ||||||||||||
| Balance at Mar. 31, 2023 | 11,089,838 | 109,074 | (3,067,047) | (124,413) | (6,351,762) | 1,655,690 | (24,934) | 1,630,756 | 1,630,756 | |||||||||
| IfrsStatementLineItems [Line Items] | ||||||||||||||||||
| Issuance of shares | 2,441,769 | (109,074) | 2,332,695 | 2,332,695 | ||||||||||||||
| Loss for the financial period, representing total comprehensive loss for the financial period | (2,304,026) | (2,304,026) | (87,135) | (2,391,161) | (2,391,161) | |||||||||||||
| Other comprehensive loss | (121,298) | (121,298) | (121,298) | (121,298) | ||||||||||||||
| Total comprehensive loss for the financial year | (121,298) | (2,304,026) | (2,425,324) | (87,135) | (2,512,459) | (2,512,459) | ||||||||||||
| Arising from part dilution of equity interest in a subsidiary | 4,122 | 4,122 | (4,122) | |||||||||||||||
| Balance at Mar. 31, 2024 | $ 13,531,607 | $ (3,067,047) | $ (245,711) | $ (8,651,666) | $ 1,567,183 | $ (116,191) | $ 1,450,992 | $ 1,450,992 | ||||||||||
| Balance at Apr. 10, 2024 | [1] | |||||||||||||||||
| IfrsStatementLineItems [Line Items] | ||||||||||||||||||
| Loss for the financial period, representing total comprehensive loss for the financial period | (6,441) | (6,441) | ||||||||||||||||
| Balance at May. 31, 2024 | [1] | $ (6,441) | $ (6,441) | |||||||||||||||
| Balance at May. 13, 2024 | $ 1 | $ 1 | ||||||||||||||||
| IfrsStatementLineItems [Line Items] | ||||||||||||||||||
| Loss for the financial period, representing total comprehensive loss for the financial period | (6,303) | (6,303) | ||||||||||||||||
| Balance at Aug. 31, 2024 | $ 1 | $ (6,303) | $ (6,302) | |||||||||||||||
| ||||||||||||||||||